EUVIMEDEUVIMED entdecken
Klinische Studie (Phase II)Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

Metastatic tropism of molecularly defined clear-cell renal cell carcinoma clusters

Gaelle Haddad, Junyu Guo, Yin Xi, Emin Albayrak, Mahrukh Huseni, Habib Hamidi, Romain Banchereau, Edward Kadel, Sarita Dubey, Corey Carter, Payal Kapur, James Brugarolas und 1 weitere

Journal of Clinical Investigation · 15.05.2026 · 136 (10)

DOI: 10.1172/jci195288 ↗

Kurz gefasst

Klinische Studie (Phase II) in der Zeitschrift Journal of Clinical Investigation, online erschienen am 15.05.2026. Verfasst von Gaelle Haddad und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, University of Texas Southwestern Medical Center, Dallas, Texas, USA. Hauptthemen laut MEDLINE: Carcinoma, Renal Cell, Kidney Neoplasms, Pancreatic Neoplasms. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Institutes of Health, US National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND The relationship between molecular subgroups in clear-cell renal cell carcinoma (ccRCC) and metastatic tropism is poorly understood. METHODS We analyzed over 5,000 metastatic sites from 305 treatment-naive ccRCC patients in the IMmotion150 phase II clinical trial, where patients were randomized to atezolizumab, atezolizumab/bevacizumab, or sunitinib. RESULTS Angiogenic tumors (clusters 1 and 2) had a higher rate of pancreatic (21% vs. 6.9%; P = 0.002) and lower absolute number of lymph node (2.5 vs. 4.2; P = 0.006) metastases. In contrast, proliferative tumors (clusters 4 and 5) exhibited a higher absolute number of lymph node metastases (5.5 vs. 3.5; P = 0.019). Patients with pancreatic metastases receiving sunitinib had higher odds of overall response (OR, 7.13; 95% CI, 1.81–28.07; P = 0.0049) and longer progression-free survival than those without pancreatic metastases ( P = 0.02). CONCLUSION ccRCC metastatic tropism relates to molecular clusters that predict response to therapy for tumors that metastasize to the pancreas. TRIAL REGISTRATION ClinicalTrials.gov NCT01984242 FUNDING NIH grants R01CA154475 and P50CA196516.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Renal CellKidney NeoplasmsPancreatic NeoplasmsHumansFemaleMaleLymphatic MetastasisMiddle AgedAntibodies, Monoclonal, HumanizedSunitinibBevacizumabAged

Stichwörter der Autor:innen

CancerClinical ResearchDiagnostic imagingMolecular geneticsOncologyPublic Health

Substanzen

Antibodies, Monoclonal, HumanizedSunitinibBevacizumabatezolizumab

Autor:innen und Institutionen

  • Department of Radiology, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
  • Genentech, San Francisco, California, USA.
  • Department of Pathology.
  • Department of Urology.
  • Kidney Cancer Program.
  • Department of Medicine, and.

Förderung

  • National Institutes of Health
  • US National Institutes of Health

Zitieren

APA

Haddad, G., Guo, J., Xi, Y., Albayrak, E., Huseni, M., Hamidi, H., Banchereau, R., Kadel, E., Dubey, S., Carter, C., Kapur, P., Brugarolas, J., & Pedrosa, I. (2026). Metastatic tropism of molecularly defined clear-cell renal cell carcinoma clusters. Journal of Clinical Investigation, 136(10). https://doi.org/10.1172/jci195288

Vancouver

Haddad G, Guo J, Xi Y, Albayrak E, Huseni M, Hamidi H, et al. Metastatic tropism of molecularly defined clear-cell renal cell carcinoma clusters. Journal of Clinical Investigation. 2026;136(10). doi:10.1172/jci195288

BibTeX
@article{Haddad2026,
  author = {Haddad, Gaelle and Guo, Junyu and Xi, Yin and Albayrak, Emin and Huseni, Mahrukh and Hamidi, Habib and Banchereau, Romain and Kadel, Edward and Dubey, Sarita and Carter, Corey and Kapur, Payal and Brugarolas, James and Pedrosa, Ivan},
  title = {Metastatic tropism of molecularly defined clear-cell renal cell carcinoma clusters},
  journal = {Journal of Clinical Investigation},
  year = {2026},
  volume = {136},
  number = {10},
  doi = {10.1172/jci195288}
}
Kostenlos starten →